The purpose of this study is to develop an integrated view of molecular mechanisms underlying CF lung disease severity.
BACKGROUND: Cystic fibrosis (CF) is a recessive genetic disorder caused by mutations in CF transmembrane conductance regulator (CFTR) gene. CF has multi-organ involvement, but respiratory disease is the major cause of morbidity and mortality. The median age of survival in CF is only 37 years, but there is a broad range of disease severity in the lung, even among patients with identical CFTR genotypes, including deltaF508 homozygotes. DESIGN NARRATIVE: This project holds great promise for defining a robust molecular phenotype for CF lung disease, which relates to prognosis, and new targets for therapy. By using a large and well-defined population of deltaF508 homozygotes who also have whole genome single nucleotide polymorphism (SNP) data, and by studying gene expression across the whole transcriptome in a large number of samples of two relevant tissues (respiratory epithelium and transformed lymphocytes), we will be uniquely positioned to develop an integrated view of molecular mechanisms underlying CF lung disease severity.
Study Type
OBSERVATIONAL
Enrollment
152
Johns Hopkins University
Baltimore, Maryland, United States
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Case Western Reserve University
Cleveland, Ohio, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.